Nucleoside with anti-hepatitis B virus activity
    2.
    发明授权
    Nucleoside with anti-hepatitis B virus activity 有权
    核苷含抗乙型肝炎病毒活性

    公开(公告)号:US06458773B1

    公开(公告)日:2002-10-01

    申请号:US09435261

    申请日:1999-11-05

    IPC分类号: A61K3170

    CPC分类号: C07H19/06 C07H19/10

    摘要: Compounds and pharmaceutical compositions active against hepatitis B virus are provided, as is a method for the treatment of hepatitis B virus infection in humans and other host animals is provided comprising administering an effective amount of a &bgr;-L-(2′or 3′-azido)-2′,3′-dideoxy-5-fluorocytosine of the formula wherein R is H, acyl, monophosphate, diphosphate, or triphosphate, or a stabilized phosphate derivative (to form a stabilized nucleotide prodrug), and R′is H, acyl, or alkyl.

    摘要翻译: 提供了针对乙型肝炎病毒的化合物和药物组合物,提供了在人和其他宿主动物中治疗乙型肝炎病毒感染的方法,包括施用有效量的β-L-(2'-3'- 叠氮基)-2',3'-二脱氧-5-氟胞嘧啶R是H,酰基,单磷酸,二磷酸或三磷酸,或稳定的磷酸酯衍生物(形成稳定的核苷酸前药),R'H, 酰基或烷基。

    &bgr;-L nucleosides for the treatment of HIV infection
    3.
    发明授权
    &bgr;-L nucleosides for the treatment of HIV infection 失效
    β-L核苷用于治疗HIV感染

    公开(公告)号:US06407077B1

    公开(公告)日:2002-06-18

    申请号:US09435268

    申请日:1999-11-05

    IPC分类号: A61K317068

    CPC分类号: A61K31/7068

    摘要: Compounds and pharmaceutical compositions active against HIV are provided, as is a method for the treatment of HIV infection in humans and other host animals is provided comprising administering an effective amount of a &bgr;-L-(2′ or 3′-azido)-2′,3′-dideoxy-5-fluorocytosine of the formula wherein R is H, acyl, monophosphate, diphosphate, or triphosphate, or a stabilized phosphate derivative (to form a stabilized nucleotide prodrug), and R′ is H, acyl, or alkyl.

    摘要翻译: 提供了对HIV有活性的化合物和药物组合物,如在人和其他宿主动物中治疗HIV感染的方法一样,提供有效量的β-L-(2'或3'-叠氮基)-2 ',3' - 二脱氧-5-氟胞嘧啶R是H,酰基,单磷酸,二磷酸或三磷酸,或稳定的磷酸酯衍生物(形成稳定的核苷酸前药),R'是H,酰基或烷基 。